Sales

All articles by Sales

Déjà vu all over again: Pfizer reduces its U.S. sales force
Déjà vu all over again: Pfizer reduces its U.S. sales force
Marc Iskowitz
January 14, 2022
5:30 am

The pharma giant is shrinking sales staff as more meetings with healthcare providers go virtual. Will others follow its lead?

No more hardcore tactics? Drugmakers recalibrate sales pitches
No more hardcore tactics? Drugmakers recalibrate sales pitches
Marc Iskowitz
October 13, 2021
5:00 am

COVID-19 has compounded physicians’ stress. Drugmakers are adjusting their promotion accordingly.

Syneos study: Hybrid detailing efforts maintain momentum
Syneos study: Hybrid detailing efforts maintain momentum
Lecia Bushak
September 17, 2021
12:07 pm

While face-to-face detailing will never entirely disappear, the digital transformation spurred by COVID-19 has altered the promotional landscape.

Populus expands sales and biz-dev teams
Populus expands sales and biz-dev teams
Larry Dobrow
April 21, 2021
4:01 pm

The company has added execs from the point-of-care and agency worlds.

Purdue’s Point of No Return
Purdue’s Point of No Return
Marc Iskowitz
February 22, 2018
9:00 pm

Purdue’s decision to pull OxyContin sales reps highlights what has been the biggest part of marketing budgets. Did we just see the tipping point?

Five things for pharma marketers to know: Monday, January 22, 2018
Five things for pharma marketers to know: Monday, January 22, 2018
Virginia Lau
January 22, 2018
3:27 pm

Sanofi to buy Bioverativ for $11.6 billion; Celgene to acquire Juno for $9 billion; Teva to lay off more than 200 in Philadelphia

Five things for pharma marketers to know: Wednesday, January 17, 2018
Five things for pharma marketers to know: Wednesday, January 17, 2018
Virginia Lau
January 17, 2018
3:20 pm

Celgene reportedly in talks to buy Juno; Novartis’ Kymriah receives fast-track reviews in U.S. and Europe; BI’s Gilotrif gets expanded approval in lung cancer

Five things for pharma marketers to know: Tuesday, December 26, 2017
Five things for pharma marketers to know: Tuesday, December 26, 2017
Virginia Lau
December 26, 2017
3:25 pm

Roche to buy Ignyta for $1.7 billion; FDA OKs Valeant eye drop for OTC sale; Kmart settles prescription drug fraud allegations

Five things for pharma marketers to know: Wednesday, December 20, 2017
Five things for pharma marketers to know: Wednesday, December 20, 2017
Virginia Lau
December 20, 2017
2:20 pm

Tax bill could lead pharma to move overseas; global pharma sales increased 45% in nine years; FDA OKs first gene therapy for rare retinal disease

Five things for pharma marketers to know: Thursday, December 14, 2017
Five things for pharma marketers to know: Thursday, December 14, 2017
Virginia Lau
December 14, 2017
3:25 pm

Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer’s biosimilar to J&J’s Remicade; Novartis to downsize generics business

  • From Our Partners